Cancer treatment has improved greatly over the past few decades, but one frightening problem still remains: relapse. Many patients go through surgery, chemotherapy, or radiation and are told their cancer is gone.
They return to normal life with hope and relief. But sometimes, years later, the cancer comes back even stronger. Doctors have long struggled to understand why this happens.
Researchers now believe that one of the main reasons is a tiny group of cells called cancer stem cells. These cells behave very differently from regular cancer cells. While most cancer cells grow quickly and are attacked by chemotherapy, cancer stem cells can “hide” in the body.
They stay quiet and inactive for long periods, almost like they are asleep. Because chemotherapy mainly targets fast-growing cells, these sleeping stem cells survive treatment. Later, they can wake up and start forming new tumors.
At Virginia Commonwealth University, Professor Umesh Desai has spent more than 30 years studying complex sugar-like molecules in the body that may help solve this problem. His work focuses on glycosaminoglycans, often called GAGs. These are long chains of natural sugars that cover the surface of almost every human cell.
They are important for many processes, such as blood clotting, inflammation, cell growth, and communication between cells. Although scientists have known about GAGs for many years, their exact roles in disease are still not fully understood.
Desai believed that GAGs could be more than just natural cell coatings. He thought they could inspire new medicines.
Natural GAGs like heparin are already used as blood thinners, but they can vary in quality and sometimes cause side effects. Desai’s lab began creating synthetic versions that copy specific parts of GAGs in a controlled and safer way.
This long research journey led to a new molecule called G2.2. Desai developed it together with Dr. Bhaumik Patel, a cancer doctor and researcher who studies colorectal and digestive cancers.
Both scientists are members of the VCU Massey Cancer Center. Their shared goal was to find a way to destroy the hidden cancer stem cells that cause tumors to return.
Desai compares cancer stem cells to a bear in winter. When the bear hibernates, it stays hidden in its den, protected from danger. No matter how strong a weapon is, it cannot reach the bear while it sleeps.
In the same way, cancer stem cells hide from chemotherapy. G2.2 works differently. It interacts with a specific receptor on the stem cells, forcing them out of their dormant state. Once these cells are active, the molecule triggers signals inside them that lead to their death.
The team tested G2.2 in many laboratory models. They found that it almost completely removed dormant stem cells in colorectal cancer. The molecule also showed similar effects in models of lung, brain, kidney, and pancreatic cancers. This suggests the approach may work for several different tumor types.
Another exciting finding was safety. In preclinical testing, G2.2 did not show major toxic effects. It even appeared to boost the immune system by activating T-cells that help the body fight cancer naturally.
G2.2 is still in the preclinical stage, but it represents a new direction in cancer therapy. Instead of only attacking fast-growing tumors, it targets the hidden roots that allow cancer to grow back.
The discovery also shows that carefully designed sugar-based molecules can control complex biological systems in ways scientists once thought impossible.
Study review and analysis: The research provides strong early evidence that targeting cancer stem cells is a promising strategy for preventing relapse. The molecule worked across several cancer types and showed good safety in lab models, which is encouraging.
However, these results are still from animal and laboratory studies. Human trials are needed to confirm whether the treatment is safe and effective in patients. If future testing succeeds, G2.2 could become an important new tool in long-term cancer control and may inspire similar therapies using synthetic GAG-based drugs.
If you care about cancer, please read studies that a low-carb diet could increase overall cancer risk, and berry that can prevent cancer, diabetes, and obesity.
For more health information, please see recent studies about how drinking milk affects the risks of heart disease and cancer and results showing vitamin D supplements could strongly reduce cancer death.
Copyright © 2025 Knowridge Science Report. All rights reserved.
